Please assess the completion status of the following clinical trial:

Trial Title: Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* OMS grade II glioma~* signed informed consent~* age \>=18~* IK \>=80%~* ability to read, write and undertand French~Exclusion Criteria:~* glioma localized to brainstem~* other neurologic or psychiatric disease~* history of other malignancies, other than curatively treated in-situ carcinoma of the cervix or basal cell carcinoma of the skin, or any other curatively treated cancer with no sign of recurrence within 5 years prior to randomization~* neuroleptic concomitant treatment~* pregnant or lactating women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- OMS grade II glioma (Type: OTHER): neurocognitive tests

Based on this trial design, predict the completion outcome and termination type (if applicable).